Association between Omentin Levels and Insulin Resistance in Pregnancy

Aktas G., Alcelik A., Ozlu T., Tosun M., Tekce B. K., Savli H., ...Daha Fazla

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.122, sa.3, ss.163-166, 2014 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 122 Sayı: 3
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1055/s-0034-1370917
  • Dergi Adı: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.163-166
  • Anahtar Kelimeler: omentin, insulin resistance, pregnancy, POLYCYSTIC-OVARY-SYNDROME, ADIPOSE-TISSUE, INFLAMMATION, ADIPOKINE, OBESITY, DISEASE, WOMEN
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Aims: Omentin is a new adipokine secreted mainly from visceral adipose tissue. Serum omentin is found to be reduced in patients with impaired glucose tolerance, type 2 diabetes mellitus, obesity and insulin resistant states. Despite the fact that pregnancy is also characterized with hyperinsulinemia, literature is lacking about data of omentin levels and its association with insulin resistance in pregnant women. We aimed to evaluate the association of omentin levels and insulin resistance in pregnant women and to compare these levels with those of non-pregnant, nondiabetic women.